RMTG unit Cellgenic begins commercial activity in Peru
RMTG•Management does not expect material impact
Management flagged no expectation that the Peru arrangements will be material, with revenue impact uncertain.
Cellgenic starts commercial activity in Peru
Regenerative Medical Technology Group’s wholly owned Global Stem Cells Group began Cellgenic commercial activity in Peru via local arrangements.
The move extends Cellgenic’s Latin American network, with Peru part of a three-market growth push alongside Brazil and Colombia.
